• NHS to fund Afinitor for TSC-related epilepsy pharmatimes
    January 03, 2019
    NHS England has announced that from April this year it will fund Novartis' Afinitor (everolimus) for patients living with Tuberous Sclerosis Complex (TSC)-related refractory epilepsy.
PharmaSources Customer Service